Spica Healthcare — Unit of Grover Hospital, Bathinda
HomeHealth Guides & BlogsGeneral Orthopaedics & Spine CareSurgery vs. Medication: When Can Spondylodiscitis (Spine Infection) Be Managed Conservatively?
General Orthopaedics & Spine Care

Surgery vs. Medication: When Can Spondylodiscitis (Spine Infection) Be Managed Conservatively?

10 min read
Aug 28, 2026
Advanced spinal imaging PET-CT and MRI showing spinal recovery and alignment

Clinical Summary & Key Takeaways

An authentic analysis by Dr. Deepak Garg on the JBJS case report evaluating when multi-level spondylodiscitis can be successfully cured without surgery. Explains spontaneous anterior auto-fusion, PET-CT watchful waiting, and clinical criteria for avoiding open spinal fusion.

Conservative Management vs. Open Spinal Instrumentation in Spondylodiscitis

When patients present with multi-level destructive spondylodiscitis—demonstrating severe intervertebral disc narrowing, vertebral endplate erosion, and localized kyphotic deformity—the traditional surgical inclination has often been to perform extensive open anterior corpectomy, bone grafting, and multi-segmental pedicle screw instrumentation. However, such major surgical interventions carry significant morbidity, extended hospitalizations, and permanent loss of spinal segment mobility.

A newly published clinical study in the Journal of Bone and Joint Surgery (JBJS Case Connector, August 2026) demonstrates that even multi-level thoracic and lumbar spondylodiscitis (Th10-11 and L1-2) with structural endplate destruction can achieve complete clinical recovery, spontaneous anterior bony auto-fusion, and full return to heavy physical labor without any surgical intervention.

What Did the Case Report Document?

The study followed a 20-year-old male who developed two-level thoracolumbar spondylodiscitis caused by Scedosporium apiospermum following vehicular water submersion. Radiographs and MRI at 2 months demonstrated:

• Multi-Level Endplate Destruction: Significant disc space narrowing and bone erosion between Th10-11 and L1-2 with elevated CRP (29 mg/L) and ESR (30 mm/h).

• Targeted Pharmacotherapy: Oral Voriconazole (400 mg daily) was initiated for a planned 12-week course. Lower back pain improved rapidly.

• Managing Adverse Drug Events: In Week 6, the patient developed lip edema and skin ulcerations diagnosed as an allergic reaction to Voriconazole. Antifungal therapy was discontinued. Due to potential cross-allergy with other azoles and Amphotericin B resistance (MIC 8 mg/L), clinicians initiated a structured 'watchful waiting' regimen.

• Functional Metabolic Monitoring with PET-CT: A 18F-FDG PET-CT at 7 months showed uptake at Th10-11 and minimal uptake at L1-2. Supine CT demonstrated a stable focal kyphosis angle of 24° at Th10-11. CRP had normalized to 4.4 mg/L. Because the patient was completely asymptomatic and neurologically intact, the watchful waiting regimen was maintained.

• Long-Term 1.5-Year Outcome: Radiographs at final follow-up showed complete anterior fusion at L1-2, stable incomplete anterior fusion at Th10-11 with a stable 24° kyphosis angle, and normal coronal alignment. Inflammatory parameters were completely normal (CRP < 0.6 mg/L, ESR 2 mm/h). The patient returned to full-time physically demanding employment with zero back complaints and zero neurological deficits, successfully avoiding surgical fusion.

Criteria for Conservative Non-Surgical Spine Management

Based on clinical evidence and standardized spine care algorithms (Duarte & Vaccaro, Eur Spine J 2013; Herren et al., Dtsch Arztebl Int 2017), conservative therapy without open instrumentation is viable when:

1. Neurological Function is Fully Preserved: Absence of progressive motor deficits, radicular paresis, or cauda equina syndrome.

2. Biomechanical Alignment is Stable: Kyphotic deformity is non-progressive (<25° to 30°) and without coronal subluxation.

3. Pathogen is Culture-Identified: Specific antimicrobial or antifungal therapy is directed by biopsy rather than blind broad-spectrum coverage.

4. Inflammatory Markers Normalize: Progressive decline in CRP and ESR correlates with biological healing and spontaneous anterior fusion.

When is Open Spine Surgery Strictly Required?

Surgical debridement and instrumentation are indicated for progressive neurological deficit from spinal cord compression, severe structural collapse threatening neural elements, or large refractory epidural abscesses unresponsive to medical treatment. In the absence of these indications, patient-specific conservative regimens offer outstanding long-term durability.

My Take on the Findings — Dr. Deepak Garg

This study illustrates an essential tenet of modern orthopaedic spine surgery: we treat the patient, not just the radiograph. Even when imaging shows marked structural disc space destruction, if the patient is neurologically intact, biologically responding, and structurally aligned, the body has an extraordinary capacity for spontaneous anterior auto-fusion. Invasive metal instrumentation can and should be avoided in properly selected patients.

Take-Home Message

• Multi-level spondylodiscitis does not automatically require open spinal fusion surgery.

• Culture-directed medical therapy can achieve spontaneous anterior auto-fusion and full functional recovery.

• When drug toxicity limits medical therapy, serial PET-CT and CRP monitoring enable safe 'watchful waiting'.

• Surgery is strictly reserved for progressive neurological deficits, significant instability, or refractory epidural collections.

Educational Disclaimer: This article is intended for medical education and scientific discussion. Individual treatment pathways must be determined by a specialist spine surgeon and infectious disease multidisciplinary team.

Reference / Bibliography

1. Koning JDR, Baltes TPA, Geeraedts L Jr, van Daalen F, van Elzakker E, Stadhouder A. Delayed Complication of Near-Drowning Following a Car Crash: Spondylodiscitis by Scedosporium apiospermum. A Case Report. JBJS Case Connect. 2026;16(3):e26.00200. doi:10.2106/JBJS.CC.26.00200.

2. Duarte RM, Vaccaro AR. Spinal infection: state of the art and management algorithm. Eur Spine J. 2013;22(12):2787-2799.

3. Herren C, Jung N, Pishnamaz M, Breuninger M, Siewe J, Sobottke R. Spondylodiscitis: diagnosis and treatment options. Dtsch Arztebl Int. 2017;114(51-52):875-882.

Frequently Asked Patient Questions

Limb Salvage with modular titanium megaprosthesis removes the tumor completely while preserving the limb, allowing patients to walk, work, and maintain full social independence without the physical disability of an artificial limb.

Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Share this medical guide:
WhatsApp
Director-Led Clinical Breakthroughs

Signature Surgical Innovations & Techniques

Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

1 of 13
Comprehensive Bone Cancer Oncology & Limb Preservation
Click to Watch Video Demonstration
95%+ Limb Salvage & MAP Chemotherapy
Multidisciplinary Limb Salvage, MAP Chemotherapy & Modular Megaprosthetics

Comprehensive Bone Cancer Oncology & Limb Preservation

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.

Key Advantages Over Conventional Surgery:
Coordinated Surgical & Medical Oncology: Seamless dual leadership under Dr. Deepak Garg & Dr. Neha Gupta
95%+ Limb Preservation Rate: Wide oncological bone resection avoiding traumatic limb amputations
High-Grade Sarcoma Chemotherapy: Standardized MAP and VIDE protocols delivering high tumor necrosis rates (>90%)
Custom Modular Megaprostheses: Immediate joint restoration with biological tendon ingrowth collars
Why Families & Physicians Trust Spica

World-Class Clinical Precision, Built on Compassion

Spica Healthcare — Bone and Cancer Institute, Bathinda — is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.

AIIMS & Tata Memorial Alumni25+ Yrs Combined Senior Leadership

15,000+ Complex Surgeries & 100% Director-Led Evaluations

Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists — Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) — guaranteeing zero junior proxies.

15,000+Surgeries Completed
95%+Limb Salvage Rate
<0.3%Infection Benchmark
Pre-Op 3D Virtual Planning 100% Direct Director OPD Day-1 Walking Protocol
Sub-Millimeter Accuracy

3D Navigated Robotics & Day-1 Walking

Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.

ROSA Robotics & Stryker Nav
Malwa Punjab Exclusive

Limb-Salvage Over Amputation

South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.

Modular Megaprosthesis
0-Out-Of-Pocket Options

100% Cashless PM-JAY & TPAs

Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.

Ayushman + 30+ TPAs Empanelled
24/7 Tertiary Ready

Class-100 Laminar Flow OTs & ICU

Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.

Spica Healthcare Bathinda
Expert Surgical Directors

Meet the Doctors at Spica Healthcare

Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Dr. Neha Gupta - Clinical Director & Senior Medical Oncologist

Dr. Neha Gupta

Senior Consultant & Clinical Director — Medical Oncology

13+ Yrs Exp

MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

Medical Oncology & ChemotherapyImmunotherapy & Targeted OncologyPrecision Oncology & Cancer GenomicsPreventive Cancer ScreeningPalliative & Supportive OncologyHormonal TherapyComprehensive Cancer Treatments
Dr. Deepak Garg - Director & Senior Joint Replacement, Spine and Orthopaedic Oncologist

Dr. Deepak Garg

Senior Consultant & Clinical Director — Orthopaedic Oncology & Robotic Joint Surgery

16+ Yrs Exp

MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)

Orthopaedic Oncology & Bone Tumors3D Robotic Joint ReplacementSports Injuries & ArthroscopyTrauma & Fracture ReconstructionGeneral Orthopaedics & Spine CareComprehensive Cancer Treatments
Community Health & Academic Outreach

Upcoming Health Camps & Academic Events

Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.

Curious what families & patients experience

Hear what our patients are saying

Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare — Grover Hospital, Bathinda.

Health Knowledge & Clinical Guides

Doctor-Authored Health Guides

Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.